| Literature DB >> 7190018 |
Abstract
The tetrazolium test for skin carcinogenicity was performed with different doses of (i) a strong, complete carcinogen with moderate cytotoxicity, 20-methylcholanthrene; (ii) a weak carcinogen with strong cytotoxicity, the promoter 12-O-tetradecanoylphorbol-13-acetate; (iii) a strong toxic substance with very weak carcinogenicity for the skin, cantharidin; and (iv) X-rays. The dose-response relationship was determined, and the validity of the tetrazolium test was confirmed. However, substances strongly cytotoxic must be tested in small doses to avoid necrosis. The tetrazolium test should not be used on the skin to test substances carcinogenic for organs other than skin.Entities:
Mesh:
Substances:
Year: 1980 PMID: 7190018 PMCID: PMC2010254 DOI: 10.1038/bjc.1980.71
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640